Chlophedianol, phenylephrine, and pyrilamine and Insulin glargine and lixisenatide Subcutaneous
Determining the interaction of Chlophedianol, phenylephrine, and pyrilamine and Insulin glargine and lixisenatide Subcutaneous and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: chlophedianol / phenylephrine / pyrilamine
Brand name: Pro-Chlo
Synonyms: n.a.
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin glargine and lixisenatide (Subcutaneous)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Chlophedianol, phenylephrine, and pyrilamine-Insulin glargine, recombinant Subcutaneous
- Chlophedianol, phenylephrine, and pyrilamine-Insulin glulisine
- Chlophedianol, phenylephrine, and pyrilamine-Insulin Glulisine (Cartridges and Pens)
- Chlophedianol, phenylephrine, and pyrilamine-Insulin Glulisine (Vials)
- Chlophedianol, phenylephrine, and pyrilamine-Insulin glulisine Subcutaneous
- Chlophedianol, phenylephrine, and pyrilamine-Insulin human inhaled Inhalation
- Insulin glargine and lixisenatide Subcutaneous-Chlophedianol/Dexbrompheniramine/Phenylephrine Liquid
- Insulin glargine and lixisenatide Subcutaneous-Chlophedianol/Guaifenesin Liquid
- Insulin glargine and lixisenatide Subcutaneous-Chlophedianol/Guaifenesin/Pseudoephedrine Tablets
- Insulin glargine and lixisenatide Subcutaneous-Chlor Trimeton Nasal Decongestant
- Insulin glargine and lixisenatide Subcutaneous-Chlor-Mal
- Insulin glargine and lixisenatide Subcutaneous-Chlor-Trimeton